Autobiographical Specificity (ESAD)

April 2, 2026 updated by: Nantes University Hospital

Autobiographical Specificity in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia

Autobiographical memory is diminished in patients with Alzheimer's Disease and those with behavioral variant of frontotemporal dementia, and research has focused on the hampered ability of patients in retrieving specific memories. However, this study proposes a detailed methodology to provide a qualitative analysis of autobiographical specificity.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Patients with Alzheimer's Disease and those with behavioral variant of frontotemporal dementia will be invited to retrieve autobiographical memories. Memories will be analyzed and categorized into specific, categoric, extended, or semantic autobiographical retrieval.

Study Type

Observational

Enrollment (Actual)

39

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nantes, France
        • EL HAJ Mohamad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All participants will be recruited through the active file of memory consultations of the "memory resource and research center" (CMRR) of the Nantes University Hospital.

Description

Inclusion Criteria:

  • Alzheimer' disease or avioral variant of frontotemporal dementia
  • No opposition from the patient to be included in the study
  • For Alzheimer's patients: a score of more than 24 out of 30 on the Mini Mental State Examination (McKhann et al., 1984)

Exclusion Criteria:

  • Other psychiatric/neurological disorders
  • Minor patients
  • Adults under guardianship or protection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Alzheimer's Disease
recruited according to criteria by National Institute on Aging (McKhann et al., 2011).

The analysis of the specificity of Autobiographical Recall will be done through the following scale, developed for the study:

  • 6 points for a recall involving a single personal event located in space AND time (e.g.,"I remember when my parents took me to the sea for the first time..in 1962..in Dunkerque")
  • 5 points for a recall involving a single personal event located in space OR time ("I remember when my parents first took me to the sea...in 1962")
  • 4 points for a recall involving a single personal event but without spatial/temporal details ("I remember when my parents took me to the sea for the first time")
  • 3 points for a recall involving a general personal event but located in space AND time ("we used to go to Dunkerque in the summer")
  • 2 points for a recall involving a general personal event but located in space OR time ("we used to go to Dunkerque")
  • 1 point for a recall involving a general personal event without spatial/temporal details ("we used to go on vacation")
Behavioral variant of frontotemporal dementia
recruited following criteria by Rascovsky et al. (2011)

The analysis of the specificity of Autobiographical Recall will be done through the following scale, developed for the study:

  • 6 points for a recall involving a single personal event located in space AND time (e.g.,"I remember when my parents took me to the sea for the first time..in 1962..in Dunkerque")
  • 5 points for a recall involving a single personal event located in space OR time ("I remember when my parents first took me to the sea...in 1962")
  • 4 points for a recall involving a single personal event but without spatial/temporal details ("I remember when my parents took me to the sea for the first time")
  • 3 points for a recall involving a general personal event but located in space AND time ("we used to go to Dunkerque in the summer")
  • 2 points for a recall involving a general personal event but located in space OR time ("we used to go to Dunkerque")
  • 1 point for a recall involving a general personal event without spatial/temporal details ("we used to go on vacation")

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Autobiographical specificity
Time Frame: 40 minutes
We will apply the method by Raes et al. (2007) to assess whether each retrieved event refers to a: specific event, categorical event, extended event, or semantic event
40 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2023

Primary Completion (Actual)

March 6, 2026

Study Completion (Actual)

March 6, 2026

Study Registration Dates

First Submitted

November 22, 2022

First Submitted That Met QC Criteria

November 30, 2022

First Posted (Actual)

December 8, 2022

Study Record Updates

Last Update Posted (Actual)

April 3, 2026

Last Update Submitted That Met QC Criteria

April 2, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alzheimer Disease

Clinical Trials on Autobiographical reminder

Subscribe